Planned sale of 7,142 common shares filed

A holder of common stock has filed a notice of intent to sell 7,142 shares, with an aggregate market value of $60,492.74.

Accepted by SEC EDGAR 01/27/2026 - 09:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of common stock has filed a notice of intent to sell 7,142 shares, with an aggregate market value of $60,492.74. The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an approximate sale date of 01/27/2026. The issuer had 88,309,441 shares outstanding at the time referenced, and the shares to be sold were acquired on 01/27/2026 through multiple RSU grants from the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing for KURA indicate?

The Form 144 indicates a planned sale of 7,142 common shares. The shares have an aggregate market value of $60,492.74 and are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services around January 27, 2026.

How many KURA shares are covered by this Form 144 notice?

The notice covers 7,142 shares of common stock. These shares correspond to restricted stock units (RSUs) acquired from the issuer on January 27, 2026 and are expected to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

What is the aggregate market value of KURA shares to be sold under this Form 144?

The aggregate market value of the shares to be sold is $60,492.74. This value applies to 7,142 common shares that are planned for sale on NASDAQ via Morgan Stanley Smith Barney LLC Executive Financial Services on or about January 27, 2026.

How were the KURA shares in this Form 144 acquired?

The shares were acquired through restricted stock unit (RSU) grants. Several RSU transactions from the issuer on January 27, 2026, totaling 7,142 shares, are listed as the source of the common stock now planned for sale under this notice.

What does the Form 144 reveal about KURA shares outstanding?

The filing notes 88,309,441 common shares outstanding. This figure serves as a baseline reference for the issuer’s capital structure at the time, against which the 7,142 shares covered by the Form 144 sale notice are relatively small.

Which broker and exchange are involved in the KURA Form 144 sale?

The sale is planned through Morgan Stanley Smith Barney LLC on NASDAQ. Specifically, the broker is Morgan Stanley Smith Barney LLC Executive Financial Services, and the securities listed for sale are common stock traded on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001910331
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KURA ONCOLOGY, INC.
SEC File Number	001-37620
Address of Issuer	4930 Directors Place, Suite 500 San Diego CALIFORNIA 92121
Phone	(858)-500-8800
Name of Person for Whose Account the Securities are To Be Sold	DOYLE THOMAS JAMES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7142	60492.74	88309441	01/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/27/2026	RSU	Issuer			2226	01/27/2026	N/A
Common Stock	01/27/2026	RSU	Issuer			1114	01/27/2026	N/A
Common Stock	01/27/2026	RSU	Issuer			695	01/27/2026	N/A
Common Stock	01/27/2026	RSU	Issuer			2226	01/27/2026	N/A
Common Stock	01/27/2026	RSU	Issuer			881	01/27/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Teresa Bair, Attorney-in-fact for Thomas Doyle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)